Form 4 for INMB Inmune Bio, Inc.
Accepted 2021-10-26 00:00:00 ET · period of report 2021-10-22 · accession 0001213900-21-054644 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-26 | 2021-10-22 | INMB | Tesi Raymond Joseph | Pres, CEO, Dir, 10% | S - Sale | $20.00 | -23.6K | 1.50M | -2% | -$472.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-22 | S | D | 23,616 | $20.00 | 1,500,817 | D | — | — |